Vimarsana
Biggest News Aggregation in the World

Individuals With Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Individuals With Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Individuals With Type Today - Breaking & Trending Today

Injection of GIP and GLP-2 may reduce bone resorption biomarker CTX in type 2 diabetes patients: Study - Vimarsana News

Injection of GIP and GLP-2 may reduce bone resorption biomarker CTX in type 2 diabetes patients: Study

Published: March 27, 2024

Denmark: A recent study published in The Journal of Clinical Endocrinology and Metabolism has shed light on the effects of exogenous glucose-dependent insulinotropic polypeptide (GIP) and...

Source: medicaldialogues.in
Related Topics:
Kirsa Skov JeppesenUniversity Of CopenhagenBone TurnoverIndividuals With TypeClinical EndocrinologyJournal Of Clinical Endocrinology And MetabolismGone TurnoverType 2 DiabetesGlucose Dependent Insulinotropic PolypeptideGlucagon Like Peptide 2Ut Bone AxisBone ResorptionBone Mineral Density
Liraglutide improves FVC in type 2 diabetes patients: LIRALUNG Study - Vimarsana News

Liraglutide improves FVC in type 2 diabetes patients: LIRALUNG Study

Published: February 15, 2022

Spain: Liraglutide may increase forced vital capacity (FVC) in type 2 diabetes patients, finds a recent study. This effect was shown to be linked to a significant decrease in circulating serum levels...

Source: medicaldialogues.in
Related Topics:
Marta GarcFranciscoj TinahonesAlfonso SotoAlbert LecubeSilvia PelliteroAnna Michela GaetaCristina HernRaquel MartSalud CarlosMireia DalmasesRafael SimAndreea CiudinInstituto De Salud CarlosFerran BarbLiraglutide Improves Forced Vital CapacityIndividuals With TypeData FromRandomized CrossoverType 2 DiabetesSurfactant ProteinForced Vital CapacityGlp 1 Receptor AgonistPulmonary FunctionDiabetes MedicationLveolar Capillary Barrier